Status:

COMPLETED

Contrast Nephropathy in Type 2 Diabetes

Lead Sponsor:

Fayoum University

Collaborating Sponsors:

Boehringer Ingelheim

Conditions:

Kidney Function Affection Upon Exposure to Radiocontrast

Diabetes

Eligibility:

All Genders

21+ years

Brief Summary

To study the effect of radiocontrast material on kidney functions in diabetics with microalbuminuria

Detailed Description

Study design: This study will be an observational prospective cohort study. Study population: Diabetics undergoing any intervention using radiocontrast material for any medical indication in Fayoum...

Eligibility Criteria

Inclusion

  • Diabetics on DPP 4 inhibitor treatment

Exclusion

  • Diabetics on insulin

Key Trial Info

Start Date :

July 1 2018

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

November 30 2018

Estimated Enrollment :

40 Patients enrolled

Trial Details

Trial ID

NCT03470454

Start Date

July 1 2018

End Date

November 30 2018

Last Update

September 16 2020

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Faculty of medicine Fayoum univesity

Al Fayyum, Egypt

2

Fayoum University

Al Fayyum, Egypt

Contrast Nephropathy in Type 2 Diabetes | DecenTrialz